Healthcare

Essen Health Care’s ACO REACH Program Achieves 22% Savings While Transforming Care for New York’s Most Vulnerable Populations

BRONX, N.Y., Dec. 9, 2024 /PRNewswire/ -- Essen Health Care is proud to announce the successful results of its 2023…

1 year ago

NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App

JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast…

1 year ago

NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App

JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast…

1 year ago

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue streamLEXINGTON, Mass., Dec.…

1 year ago

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)…

1 year ago

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic Assessment

Prolaris Remains a Long-Standing Fixture in the Guidelines for 10th Year RunningSALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch

Strong Eversense® 365 early launch indicators illustrated by largest number of new patient shipments and largest number of prescribing providers…

1 year ago

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

Topline data from ATTENTION-AD Open-Label-Extension (OLE) 96/144-Week trial J.P. Morgan 2025 Healthcare Conference, taking place January 13–16, 2025, in San…

1 year ago